menu
    • menu

    Company profile for C4X Discovery

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    C4X Discovery (“C4XD”) is a pioneering Drug Discovery company combining scientific expertise with cutting-edge Drug Discovery technologies to efficiently deliver world‑leading medicines, which are developed by our partners for the benefit of patients. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced DNA-based target identification and candidate molecule design capabilities, gen...
    C4X Discovery (“C4XD”) is a pioneering Drug Discovery company combining scientific expertise with cutting-edge Drug Discovery technologies to efficiently deliver world‑leading medicines, which are developed by our partners for the benefit of patients. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced DNA-based target identification and candidate molecule design capabilities, generating small molecule drug candidates across multiple disease areas including inflammation, neurodegeneration, oncology and addictive disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    C4X Discoveryunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Manchester One 53 Portland Street Manchester M1 3LD
    Telephone
    Telephone
    +44 (0)161 235 5085
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.c4xdiscovery.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    C4x Discovery Selects Once-Daily Candidate From ?4?7 Inhibitor
    C4x Discovery Selects Once-Daily Candidate From ?4?7 Inhibitor

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3153649/0/en/C4X-Discovery-announces-selection-of-a-once-daily-development-candidate-from-its-%CE%B14%CE%B27-inhibitor-programme.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    C4X Discovery receives latest milestone payment from Sanofi
    C4X Discovery receives latest milestone payment from Sanofi

    27 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/27/3088350/0/en/C4X-Discovery-receives-latest-milestone-payment-from-Sanofi.html

    GLOBENEWSWIRE
    27 May 2025
    Share Share
    PatientSeek Finds Genetic Signature For IBD Therapy Response
    PatientSeek Finds Genetic Signature For IBD Therapy Response

    16 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/16/2946376/0/en/PatientSeek-identifies-a-genetic-signature-that-separates-a4b7-integrin-therapy-responder-and-non-responder-populations-in-inflammatory-bowel-disease.html

    GLOBENEWSWIRE
    16 Sep 2024
    Share Share
    C4X Discovery Reports On Programs And Appoints New Board Members
    C4X Discovery Reports On Programs And Appoints New Board Members

    22 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/22/2916293/0/en/C4X-Discovery-Holdings-Limited-announces-progress-on-immuno-inflammation-programmes-and-appointment-of-new-Board-members.html

    GLOBENEWSWIRE
    22 Jul 2024
    Share Share
    C4X Discovery Holdings Announces Divestment of Orexin-1 to Indivior for £15.95m
    C4X Discovery Holdings Announces Divestment of Orexin-1 to Indivior for £15.95m

    01 Aug 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=771387&lang=en

    ACCESSWIRE
    01 Aug 2023
    Share Share
    C4X sells substance disorder drug rights to Indivior for $20M
    C4X sells substance disorder drug rights to Indivior for $20M

    01 Aug 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/c4x-sells-full-rights-substance-disorder-drug-indivior-part-inflammation-refocus

    James Waldron FIERCE BIOTECH
    01 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search